EP Patent

EP2599477A1 — 4-Phenylbutyric acid sustained release formulation

Assigned to Lunamed AG · Expires 2013-06-05 · 13y expired

What this patent protects

The present invention refers to a sustained release formulation for 4-phenylbutyric acid which comprises pellets containing 4-PBA, wherein the 4-PBA is in the form of the free acid. The invention relates further to the preparation of the pellet formulation and their therapeutical…

USPTO Abstract

The present invention refers to a sustained release formulation for 4-phenylbutyric acid which comprises pellets containing 4-PBA, wherein the 4-PBA is in the form of the free acid. The invention relates further to the preparation of the pellet formulation and their therapeutical use.

Drugs covered by this patent

Patent Metadata

Patent number
EP2599477A1
Jurisdiction
EP
Classification
—
Expires
2013-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Lunamed AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.